| Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants X Shi, R Liu, F Basolo, R Giannini, X Shen, D Teng, H Guan, Z Shan, ... The Journal of Clinical Endocrinology & Metabolism 101 (1), 264-274, 2016 | 253 | 2016 |
| Separate enrichment analysis of pathways for up-and downregulated genes G Hong, W Zhang, H Li, X Shen, Z Guo Journal of the Royal Society Interface 11 (92), 20130950, 2014 | 200 | 2014 |
| The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer F Wang, X Yu, X Shen, G Zhu, Y Huang, R Liu, D Viola, R Elisei, ... The Journal of Clinical Endocrinology & Metabolism 102 (9), 3241–3250, 2017 | 114 | 2017 |
| The genetic duet of BRAF V600E and TERT promoter mutations robustly predicts loss of radioiodine avidity in recurrent papillary thyroid cancer J Liu, R Liu, X Shen, G Zhu, B Li, M Xing Journal of Nuclear Medicine 61 (2), 177-182, 2020 | 113 | 2020 |
| Patient Age–Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer X Shen, G Zhu, R Liu, D Viola, R Elisei, E Puxeddu, L Fugazzola, ... Journal of Clinical Oncology 36 (5), 438-445, 2018 | 113 | 2018 |
| A six-genotype genetic prognostic model for papillary thyroid cancer X Shen, R Liu, M Xing Endocrine-related cancer, ERC-16-0402, 2017 | 84 | 2017 |
| BRAF V600E mutation-assisted risk stratification of solitary intrathyroidal papillary thyroid cancer for precision treatment Y Huang, S Qu, G Zhu, F Wang, R Liu, X Shen, D Viola, R Elisei, ... JNCI: Journal of the National Cancer Institute 110 (4), 362-370, 2018 | 81 | 2018 |
| BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer F Wang, S Zhao, X Shen, G Zhu, R Liu, D Viola, R Elisei, E Puxeddu, ... Journal of Clinical Oncology 36 (27), 2787-2795, 2018 | 66 | 2018 |
| REC8 is a novel tumor suppressor gene epigenetically robustly targeted by the PI3K pathway in thyroid cancer D Liu, X Shen, G Zhu, M Xing Oncotarget 6 (36), 39211, 2015 | 61 | 2015 |
| BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer Y Tao, F Wang, X Shen, G Zhu, R Liu, D Viola, R Elisei, E Puxeddu, ... The Journal of Clinical Endocrinology & Metabolism 106 (11), 3228-3238, 2021 | 59 | 2021 |
| BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma KJ Kim, SG Kim, J Tan, X Shen, D Viola, R Elisei, E Puxeddu, L Fugazzola, ... European Journal of Cancer 124, 161-169, 2020 | 52 | 2020 |
| Response. T Zhang, X Shen, M Xing Journal of the National Cancer Institute 108 (8), 2016 | 33* | 2016 |
| Distinct functional patterns of gene promoter hypomethylation and hypermethylation in cancer genomes X Shen, Z He, H Li, C Yao, Y Zhang, L He, S Li, J Huang, Z Guo Public Library of Science 7 (9), e44822, 2012 | 32 | 2012 |
| Reproducibility and concordance of differential DNA methylation and gene expression in cancer C Yao, H Li, X Shen, Z He, L He, Z Guo PLoS One 7 (1), e29686, 2012 | 27 | 2012 |
| RNAPhaSep: a resource of RNAs undergoing phase separation H Zhu, H Fu, T Cui, L Ning, H Shao, Y Guo, Y Ke, J Zheng, H Lin, X Wu, ... Nucleic Acids Research 50 (D1), D340–D346, 2022 | 23 | 2022 |
| Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2 R Liu, J Tan, X Shen, K Jiang, C Wang, G Zhu, M Xing Proceedings of the National Academy of Sciences 118 (11), e2022779118, 2021 | 21 | 2021 |
| Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness T Zhang, X Shen, R Liu, G Zhu, J Bishop, M Xing Oncotarget 8 (1), 900, 2016 | 18 | 2016 |
| An integrated approach to uncover driver genes in breast cancer methylation genomes X Shen, S Li, L Zhang, H Li, G Hong, XX Zhou, T Zheng, W Zhang, C Hao, ... PLoS One 8 (4), e61214, 2013 | 18 | 2013 |
| Rank-based predictors for response and prognosis of neoadjuvant taxane-anthracycline-based chemotherapy in breast cancer L Zhang, C Hao, X Shen, G Hong, H Li, X Zhou, CY Liu, Z Guo Breast cancer research and treatment 139, 361-369, 2013 | 15 | 2013 |
| Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer W Cheng, X Shen, M Xing PLoS One 14 (10), e0221093, 2019 | 13 | 2019 |
Rengyun LiuInstitute of Precision Medicine, The First Affiliated Hospital of Sun Yat-sen UniversityVerified email at mail.sysu.edu.cn